
Journal of labelled compounds and radiopharmaceuticals p. 1277 - 1288 (1999)
Update date:2022-08-02
Topics:
Wilson, Alan A.
Houle, Sylvain
The potent and selective serotonin reuptake inhibitor, N,N-dimethyl-2-(2-amino-4-trifluoromethylphenylthio)benzylamine (1), and a potential metabolite, N-methyl-2-(2-amino-4-trifluoromethylphenylthio)benzylamine (2) were radiolabelled with Carbon-11 as potential positron emission tomography (PET) radiotracers. Both [11C]-(1) and [11C]-(2) were obtained in good radiochemical yield by alkylation of their respective normethyl precursors with [11C]-iodomethane in dimethylformamide. Upon HPLC purification and formulation radiochemically pure products were obtained in 25-30% yield (from [11C]-iodomethane, uncorrected) with specific activities of 25-40 GBq/mole. To further establish the site of labeling, [13C]-(1) and [13C]-(2) were also synthesised, using [13C]-iodomethane, for 13C NMR analysis. Preliminary biodistribution studies in rats show that both [11C]-(1) and [11C]-(2) efficiently and rapidly cross the blood brain barrier.
Wuxi Zuping Food Science And Technology Co.,LTD.
Contact:+86-510-87210822
Address:Guanlin town
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Contact:86-571-61063068
Address:LINAN
Jinhua Haoyuan Chemical CO., LTD(expird)
Contact:86-579-82465583
Address:Jinhua,Zhejiang
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Doi:10.1246/cl.2000.400
(2000)Doi:10.1021/jm00328a020
(1965)Doi:10.1021/jo00928a033
(1974)Doi:10.1016/j.tetlet.2011.10.148
(2011)Doi:10.1021/jo9915426
(2000)Doi:10.1016/S0040-4039(01)98203-6
(1970)